MS SB2726

Creates the Mississippi Opioid Settlement Fund Advisory Council to review grant applications and recommend appropriations from opioid settlement proceeds to the Legislature

Council consists of 15 voting members including the Attorney General (chair), State Health Officer, and appointees from the Governor, Lieutenant Governor, Speaker of the House, and various associations, plus 18 nonvoting advisory members

Settlement funds come from litigation with distributors (Cardinal Health, McKesson, AmerisourceBergen), manufacturers (Purdue Pharma, Janssen/Johnson & Johnson, Allergan, Teva), and pharmacy chains (CVS, Walgreens, Walmart, Kroger)

Legislature may accept or reject each grant recommendation but cannot modify the recommended recipients or amounts; nonabatement funds (up to 30% of total) may be appropriated without council recommendations

Council must submit annual reports by December 1 summarizing fund distribution and program outcomes, and will terminate when all settlement funds have been received and disbursed